Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
PetVivo Holdings Inc. Warrant (PETVW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/09/2025: PETVW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -20% | Avg. Invested days 6 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/09/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.85 | 52 Weeks Range 0.03 - 0.10 | Updated Date 06/22/2025 |
52 Weeks Range 0.03 - 0.10 | Updated Date 06/22/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.48 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -301.45% |
Management Effectiveness
Return on Assets (TTM) -159.92% | Return on Equity (TTM) -8616.61% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 16029244 |
Shares Outstanding - | Shares Floating 16029244 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
PetVivo Holdings Inc. Warrant
Company Overview
History and Background
PetVivo Holdings, Inc. is a biomedical company established in 2009 focused on the development and commercialization of innovative medical devices and therapeutics for companion animals. The warrants are derivative securities, allowing the holder to purchase PetVivo's common stock under specific conditions.
Core Business Areas
- Veterinary Medical Devices: Development and commercialization of injectable therapeutics for osteoarthritis and other musculoskeletal conditions in dogs, cats, and horses.
Leadership and Structure
The leadership team includes individuals with experience in veterinary medicine, biotechnology, and finance. The organizational structure is typical of a small publicly traded company, with departments focusing on R&D, sales, and marketing.
Top Products and Market Share
Key Offerings
- Spryng with OsteoCushion Technology: An injectable veterinary medical device designed to treat osteoarthritis in dogs, cats and horses. Market share information is not publicly available. Competitors include Arthramid Vet, Adequan, and other joint supplements.
Market Dynamics
Industry Overview
The veterinary medicine market is experiencing growth driven by increasing pet ownership and rising spending on pet healthcare.
Positioning
PetVivo aims to differentiate itself through its focus on regenerative medicine and proprietary OsteoCushion Technology. Competitive advantages include intellectual property and potential for improved efficacy compared to existing treatments.
Total Addressable Market (TAM)
The TAM for veterinary osteoarthritis treatments is estimated in the hundreds of millions of dollars annually. PetVivo's positioning allows it to capture a portion of this market through novel and targeted therapies.
Upturn SWOT Analysis
Strengths
- Proprietary OsteoCushion Technology
- Focus on regenerative medicine
- Potential for improved efficacy
- Dedicated Veterinary Focus
Weaknesses
- Limited market share and brand recognition
- Dependence on key product
- Limited financial resources compared to larger competitors
- Warrant overhang can dilute share value
Opportunities
- Expanding product line to address other veterinary conditions
- Partnerships with veterinary clinics and distributors
- Increasing pet ownership and spending on pet healthcare
- Geographic expansion into new markets
Threats
- Competition from established players with larger market share
- Regulatory hurdles and clinical trial requirements
- Economic downturn affecting pet spending
- Development of competing technologies by other companies
Competitors and Market Share
Key Competitors
- ZOETIS (ZTS)
- ELANCO (ELAN)
- IDXX Laboratories (IDXX)
Competitive Landscape
PetVivo faces intense competition from larger, more established players. Its advantage lies in its innovative technology, but it needs to effectively scale production and marketing to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is tied to PetVivo Holdings Inc. growth and adoption of their products.
Future Projections: Future projections depend on product approvals, market penetration, and overall industry growth in the veterinary market.
Recent Initiatives: Recent initiatives include expanding the sales force, securing partnerships with distributors, and conducting clinical trials to support product claims.
Summary
PetVivo Holdings Inc. is a developing company in the animal health market with an innovative OsteoCushion technology. Its success hinges on the continued adoption of its products by veterinary practitioners. The company faces competition from much larger entities, and it requires sustained financial resources to achieve market penetration. The warrant value depends on PetVivo's stock performance; it is a speculative bet on the company's future success. Investors should carefully assess their risk tolerance before investing in PetVivo's warrants.
Peer Comparison
Sources and Disclaimers
Data Sources:
- PetVivo Holdings Inc. Investor Relations
- Industry Reports
- Market Analysis
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual due diligence and consultation with a financial professional. Market share percentages are estimations.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About PetVivo Holdings Inc. Warrant
Exchange NASDAQ | Headquaters Edina, MN, United States | ||
IPO Launch date 2021-08-11 | CEO, President & Director Mr. John Lai | ||
Sector Healthcare | Industry Medical Devices | Full time employees 20 | Website https://www.petvivo.com |
Full time employees 20 | Website https://www.petvivo.com | ||
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.